Medroxyprogesterone Acetate and Tofacitinib Extended-Release Tablets
Determining the interaction of Medroxyprogesterone Acetate and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: medroxyprogesterone
Brand name: Provera, Depo-Provera, Depo-subQ provera 104, Depo-Provera Contraceptive
Synonyms: Medroxyprogesterone, MedroxyPROGESTERone
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Medroxyprogesterone Acetate-Tofacitinib Tablets
- Medroxyprogesterone Acetate-Tofranil
- Medroxyprogesterone Acetate-Tofranil injection
- Medroxyprogesterone Acetate-Tofranil-PM
- Medroxyprogesterone Acetate-Tol-Tab
- Medroxyprogesterone Acetate-Tolazamide
- Tofacitinib Extended-Release Tablets-Medroxyprogesterone injection
- Tofacitinib Extended-Release Tablets-Medroxyprogesterone Injection (400 mg/mL)
- Tofacitinib Extended-Release Tablets-Medroxyprogesterone Injection (Intramuscular)
- Tofacitinib Extended-Release Tablets-Medroxyprogesterone Injection (Subcutaneous)
- Tofacitinib Extended-Release Tablets-Medroxyprogesterone Injection ER
- Tofacitinib Extended-Release Tablets-Medroxyprogesterone Intramuscular